The United Nations Office at Geneva
Multimedia Newsroom
STORYLINE
Injectable HIV medicines deal to provide access to generic lifesaver in developing nations
A landmark agreement has been reached allowing for the production of low-cost, injectable HIV medicines in some 90 developing countries where more the majority of infections occur, UNITAID said on Friday.
Selected manufacturers will be able to develop, manufacture and supply lower-cost generic versions of long-acting Cabotegravir (CAB-LA), in line with a deal reached with pharmaceutical firm ViiV Healthcare (ViiV).
“The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to Cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries,” said UNITAID spokesperson Hervé Verhoosel.
The deal is significant because Cabotegravir injections are only needed once every few months. Increasing its supply at a cost that is affordable to low-income countries could help to overcome the stigma that’s associated with taking daily HIV pills - and the burden of having to remember to take them.
“In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV won’t ask for any royalty on the product and for 10 of those countries, ViiV is asking for a smaller-than-usual royalty,” Mr. Verhoosel explained.
The agreement comes after UNITAID-led discussions began in May this year with ViiV, a subsidiary of pharma giant GlaxoSmithkline. It is only seven months since Cabotegravir LA received regulatory approval.
But the process of selecting the companies that will develop, manufacture and supply generic versions of Cabotegravir will take much longer.
“This product will not be there for everybody, that’s first for people who are there the most at risk,” said Mr. Verhoosel, who noted that the cost of the medicine in the US when it comes onstream there “really soon”, was likely to be around $20,000. “That’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
According to UNITAID, the deal offers the possibility of making the injectable prophylactic medicine available in 90 countries where more than 70 per cent of all new HIV infections occurred in 2020.
Up to three drug manufacturers will be licensed to develop the product on a generic basis to avoid supply and distribution issues. “That’s done in a way that we’re sure (that) one, it’s easy for logistics, two…availability, and three, of course, that it will help to bring the cost of the generic version down”, said Mr. Verhoosel.
ends
STORY: Injectable HIV Prevention Medicines Deal - UNITAID
TRT: 02’05”
SOURCE: UNTV CH
RESTRICTIONS: NONE
LANGUAGE: ENGLISH/NATS
ASPECT RATIO: 16:9
DATELINE: Friday 29 July 2022, GENEVA, SWITZERLAND
SHOTLIST
- Medium shot, UN Geneva flag alley.
- Wide shot, press room with panel of speakers, journalists, TV camera on tripod.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “The Medicines Patent Pool, a structure created and largely funded by UNITAID, has reached a voluntary licensing agreement for patents relating to cabotegravir long-acting, an injectable form of HIV prevention, or PrEP, to generic formulations of the product in least-developed, low-income, lower-middle income and sub-Saharan African countries.”
- Medium shot, lateral, podium speakers.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “In the 90 countries that we are talking about, 80 countries are royalty-free, meaning that ViiV (ViiV Healthcare) don’t ask any royalty on the product and for 10 of those countries ViiV is asking for a smaller-than-usual royalty.”
- Wide shot, journalists, TV camera, light panel.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This product will not be there for everybody, that’s first for people who are there the most at risk. That’s a product that’s available in the US, and the price of that product for one year in the US for example is approximately 20,000 US dollars, and that’s a lot of money; that’s why that product cannot be used in low and middle-income countries.”
- Medium shot, journalists seated at tables, TV camera.
- SOUNDBITE (ENGLISH) Hervé Verhoosel, UNITAID: “This licence will actually give the option to three different generic manufacturers to develop the product on a generic base. That means that the price that those companies will have we don’t know yet, but that will not only be one company, that will be three different companies and that’s done in a way that we’re sure one, that it’s easy for logistics, two, that ensuring availability, and three, of course, that it will help to bring the cost of the generic version down.”
- Medium shot, journalists.
- Wide shot, journalists, TV camera and light panel.
- Medium shot, journalist.
- Medium shot, journalists, side shot.
Similar Stories
1
1
1
Edited News | OHCHR
Institutionalised forced labour by the Democratic People's Republic of Korea constitutes grave violations of human rights – UN report
1
1
1
Edited News | WHO
Time is running out for starving civilians in Sudan, UN humanitarians warned on Tuesday, while talks involving the country’s warring parties continue in Geneva this week.
1
1
1
Edited News | WHO
DRC faces a severe humanitarian crisis with 25M in need and rising conflict-related issues.
1
1
1
Edited News | UNRWA
A gimmer of good news emerged from Gaza on Tuesday as patients returned to at a newly reopened UN health centre in Khan Younis, six months after it was severely damaged and forced to close by heavy fighting, the UN agency for Palestine refugees (UNRWA) said.
1
1
1
Edited News | OHCHR , UNOG
UN condemns attacks on Kyiv hospitals, calls for immediate action to protect civilians.
1
1
2
Edited News | WHO
In Gaza, soaring temperatures, hunger and unsanitary conditions present an ever more deadly threat to a population under constant attack, UN humanitarians warned on Tuesday.
1
1
1
Edited News | OCHA , WMO , IFRC
Hurricane Beryl smashes into Caribbean, turns sights on Mexico As Hurricane Beryl’s destructive path shifted to Mexico on Friday after roiling the Caribbean, UN agencies and partners said that the emergency response was underway, before warning that a very long and damaging hurricane season looks increasingly likely.
1
1
2
Edited News | IOM , mcc , UNHCR
Refugees and migrants continue to face extreme forms of violence, exploitation and death on sea and on land across Africa as they attempt to leave the continent, UN agencies said on Friday, in an appeal to border authorities to do more to protect them.
1
1
1
Edited News | OHCHR
UN Human Rights Chief Volker Türk at the 56th Human Rigths Council, made the following update on the situation of human rights in the Bolivarian Republic of Venezuela.
1
1
1
Edited News | UNRWA , WHO
New evacuation orders issued by the Israeli army for areas in southern Gaza are expected to impact 250,000 people, including eastern Khan Younis and Rafah, UN humanitarians said on Tuesday.
1
1
1
Edited News | UNRWA , WHO
Gaza: People are desperate, they need everything, says UN aid agency Panic and desperation now grip ordinary Gazans struggling to survive, UN humanitarians said on Friday, amid fuel shortages of fuel and dwindling supplies that have prevented aid teams from doing their job.
1
1
1
Edited News | OCHA
UN aid teams and partner organizations remain deeply committed to delivering lifesaving supplies into Gaza, despite the increasing dangers of working there, the Organization’s top aid official said on Wednesday.